![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/04 | |
A61K 31/4709 | |||
A61P 31/04 |
(11) | Number of the document | 3112359 |
(13) | Kind of document | T |
(96) | European patent application number | 16177827.9 |
Date of filing the European patent application | 2012-11-09 | |
(97) | Date of publication of the European application | 2017-01-04 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
2011246209 | 2011-11-10 | JP | |
2012071739 | 2012-03-27 | JP |
(72) |
Araya, Ichiro, JP
Goto, Akinori, JP
Minagawa, Wataru, JP
Funada, Keiko, JP
Nagao, Muneki, JP
|
(73) |
Kyorin Pharmaceutical Co., Ltd.,
6, Kanda Surugadai 4-chome Chiyoda-ku, Tokyo 101-8311,
JP
|
(54) | 7-{(3S,4S)-3-[(CYCLOPROPYLAMINO)METHYL]-4-FLUOROPYRROLIDINE-1-YL}-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID CRYSTAL |
7-{(3S,4S)-3-[(CYCLOPROPYLAMINO)METHYL]-4-FLUOROPYRROLIDINE-1-YL}-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID CRYSTAL |